The Association of Tau With Mitochondrial Dysfunction in Alzheimer's Disease

被引:164
|
作者
Cheng, Ying [1 ]
Bai, Feng [2 ]
机构
[1] Southeast Univ, Sch Med, Affiliated ZhongDa Hosp, Dept Neurol, Nanjing, Jiangsu, Peoples R China
[2] Nanjing Univ, Med Sch, Drum Tower Hosp, Dept Neurol, Nanjing, Jiangsu, Peoples R China
来源
FRONTIERS IN NEUROSCIENCE | 2018年 / 12卷
基金
中国国家自然科学基金;
关键词
Alzheimer's disease; tau; mitochondrial transport; mitochondrial dynamics; mitochondrial dysfunction; AXONAL-TRANSPORT DEFECTS; OXIDATIVE STRESS; PHOSPHORYLATED TAU; AMYLOID-BETA; NEURODEGENERATIVE DISEASES; HYPERPHOSPHORYLATED TAU; SYNAPTIC DYSFUNCTION; ABNORMAL INTERACTION; MOUSE MODEL; PROTEIN-TAU;
D O I
10.3389/fnins.2018.00163
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Increasing evidence suggests that abnormally hyperphosphorylated tau plays a vital role in the pathogenesis of Alzheimer's disease (AD). Mitochondrial dysfunction also has a recognized role in the pathophysiology of AD. In recent years, mitochondrial dysfunction has been strongly associated with tau pathology in AD. Overexpression of hyperphosphorylated and aggregated tau appears to damage the axonal transport, leading to abnormal mitochondrial distribution. In addition, pathological tau impairs mitochondrial dynamics by regulating mitochondrial fission/fusion proteins, and further causes mitochondrial dysfunction and neuronal damage. Moreover, mitochondrial dysfunction is also involved in promoting tau pathology in AD. In this article, we evaluate the relationship between phosphorylated tau and mitochondrial dysfunction in AD.
引用
收藏
页数:6
相关论文
共 50 条
  • [21] Synaptic Dysfunction in Alzheimer’s Disease: Aβ, Tau, and Epigenetic Alterations
    Ke Li
    Qing Wei
    Fang-Fang Liu
    Fan Hu
    Ao-ji Xie
    Ling-Qiang Zhu
    Dan Liu
    Molecular Neurobiology, 2018, 55 : 3021 - 3032
  • [22] Synaptic Dysfunction in Alzheimer's Disease: Aβ, Tau, and Epigenetic Alterations
    Li, Ke
    Wei, Qing
    Liu, Fang-Fang
    Hu, Fan
    Xie, Ao-ji
    Zhu, Ling-Qiang
    Liu, Dan
    MOLECULAR NEUROBIOLOGY, 2018, 55 (04) : 3021 - 3032
  • [23] The role of mitochondrial dysfunction in Alzheimer's disease pathogenesis
    Ashleigh, Theophania
    Swerdlow, Russell H.
    Beal, M. Flint
    ALZHEIMERS & DEMENTIA, 2023, 19 (01) : 333 - 342
  • [24] The Role of Mitochondrial Dysfunction in the Progression of Alzheimer's Disease
    Desler, Claus
    Lillenes, Meryl S.
    Tonjum, Tone
    Rasmussen, Lene Juel
    CURRENT MEDICINAL CHEMISTRY, 2018, 25 (40) : 5578 - 5587
  • [25] Mitochondrial Dysfunction and Stress Responses in Alzheimer's Disease
    Weidling, Ian
    Swerdlow, Russell H.
    BIOLOGY-BASEL, 2019, 8 (02):
  • [26] Alzheimer's disease: A lesson from mitochondrial dysfunction
    Moreira, Paula I.
    Santos, Maria S.
    Oliveira, Catarina R.
    ANTIOXIDANTS & REDOX SIGNALING, 2007, 9 (10) : 1621 - 1630
  • [27] Oxidative stress and mitochondrial dysfunction in Alzheimer's disease
    Wang, Xinglong
    Wang, Wenzhang
    Li, Li
    Perry, George
    Lee, Hyoung-gon
    Zhu, Xiongwei
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2014, 1842 (08): : 1240 - 1247
  • [28] Axonal Transport and Mitochondrial Dysfunction in Alzheimer's Disease
    Riemer, Jan
    Kins, Stefan
    NEURODEGENERATIVE DISEASES, 2013, 12 (03) : 111 - 124
  • [29] Oxidative stress, mitochondrial dysfunction and Alzheimer's disease
    Georgios Hadjigeorgiou
    Annals of General Psychiatry, 7 (Suppl 1)
  • [30] Mitochondrial dysfunction and Alzheimer's disease: New developments
    Mancuso, Michelangelo
    Siciliano, Gabriele
    Filosto, Massimiliano
    Murri, Luigi
    JOURNAL OF ALZHEIMERS DISEASE, 2006, 9 (02) : 111 - 117